Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report.

Bruno Thizon Menegali Fabiana Schuelter Trevisol Alexandre Naime Barbosa Talita Menegali Izidoro Otto Henrique May Feurschuette Chaiana Esmeraldino Mendes Marcon Daisson Jose Trevisol

Published in: Revista da Sociedade Brasileira de Medicina Tropical (2021)

The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.

Keyphrases

sars cov
respiratory syndrome coronavirus
pregnant women
coronavirus disease
pregnancy outcomes
preterm birth
liver failure
gestational age
birth weight
single cell
emergency department
drug induced
case report
physical activity
aortic dissection
cord blood